Soretolide | CAS# 130403-08-6 | anticonvulsant

MedKoo Cat#: 413442 | Name: Soretolide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Soretolide is an orally active benzamide derivative with anticonvulsant effects and a similar profile of activity to carbamazepine

Chemical Structure

Soretolide

CAS#130403-08-6

Theoretical Analysis

MedKoo Cat#: 413442

Name: Soretolide

CAS#: 130403-08-6

Chemical Formula: C13H14N2O2

Exact Mass: 230.1055

Molecular Weight: 230.27

Elemental Analysis: C, 67.81; H, 6.13; N, 12.17; O, 13.90

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Soretolide; D2916; D-2916; D 2916

IUPAC/Chemical Name

Benzamide, 2,6-dimethyl-N-(5-methyl-3-isoxazolyl)-

InChi Key

GBTKANSDFYFQBK-UHFFFAOYSA-N

InChi Code

InChI=1S/C13H14N2O2/c1-8-5-4-6-9(2)12(8)13(16)14-11-7-10(3)17-15-11/h4-7H,1-3H3,(H,14,15,16)

SMILES Code

O=C(NC1=NOC(C)=C1)C2=C(C)C=CC=C2C

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

	Solvent	mg/mL	mM	comments
Solubility
	Soluble in DMSO	0.0	100.00

Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 230.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Fatope MO. Soretolide (Laboratoires Biocodex). Curr Opin Investig Drugs. 2001 Jun;2(6):824-7. PMID: 11572664. 2: Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep. 2009 Mar-Apr;61(2):197-216. doi: 10.1016/s1734-1140(09)70024-6. PMID: 19443931. 3: Walker MC, Sander JW. New anti-epileptic drugs. Expert Opin Investig Drugs. 1999 Oct;8(10):1497-1510. doi: 10.1517/13543784.8.10.1497. PMID: 11139806. 4: Jain KK. An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development. Expert Opin Investig Drugs. 2000 Apr;9(4):829-40. doi: 10.1517/13543784.9.4.829. PMID: 11060713. 5: Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res. 1999 Mar;34(1):1-41. doi: 10.1016/s0920-1211(98)00108-9. PMID: 10194110. 6: Maurizis JC, Madelmont JC, Rapp M, Marijnen C, Cerf MC, Gillardin JM, Lepage F, Veyre A. Disposition and metabolism of 2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl) (D2916) in male and female rats. Drug Metab Dispos. 1997 Jan;25(1):33-9. PMID: 9010627.